biotech
biotech Articles
Selecta Biosciences shares pushed higher on Friday after the company provided an update on its new streamlined structure under its new president and CEO.
Published:
Last Updated:
Epizyme shares jumped on Friday after the company announced a set of pipeline updates as well as a key update from the FDA.
Published:
Last Updated:
Novavax shares jumped early on Friday after the company reported that its midstage flu vaccine had some positive results.
Published:
Last Updated:
Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen for its treatment of secondary hyperparathyroidism in adult patients with chronic...
Published:
Last Updated:
Catabasis shares jumped on Thursday after the company provided an update from its late-stage trial for edasalonexent in Duchenne muscular dystrophy.
Published:
Last Updated:
Atara Biotherapeutics shares dipped on Thursday after the company provided a few business updates.
Published:
Last Updated:
Sesen Bio shares took a beating on Thursday despite posting positive data for its late-stage trial for patients with high-grade non-muscle invasive bladder cancer.
Published:
Last Updated:
DBV Technologies shares made a handy gain on Thursday after the company announced that it would be making some changes in its senior leadership ahead of its anticipated resubmission of its Viaskin...
Published:
Last Updated:
Here is a review of the outlook and expectations for 2019 in seven top biotechs valued at $20 billion or more.
Published:
Last Updated:
Clinical-stage biotechnology company Stealth Biotherapeutics has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Could this small clinical-stage emerging pharmaceuticals outfit have upside of almost 200%? That's what one firm has said on the first trading day of 2019.
Published:
Last Updated:
Cara Therapeutics shares jumped on Wednesday after the firm announced a key update in its late-stage chronic kidney disease trial.
Published:
Last Updated:
Immunotherapy company TCR2 Therapeutics has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Opko Health shares shot up on Friday after the firm announced that it has settled with the SEC with regard to charges against the company's CEO.
Published:
Last Updated:
Clinical-stage immunotherapy company Harpoon Therapeutics has filed with the SEC for its initial public offering.
Published:
Last Updated: